Gold MS - Search Results

1

Risks and Benefits of Cannabis and Cannabinoids in Psychiatry.

Hill KP, Gold MS, Nemeroff CB, McDonald W, Grzenda A, Widge AS, Rodriguez C, Kraguljac NV, Krystal JH, Carpenter LL. Hill KP, et al. Among authors: gold ms. Am J Psychiatry. 2022 Feb;179(2):98-109. doi: 10.1176/appi.ajp.2021.21030320. Epub 2021 Dec 8. Am J Psychiatry. 2022. PMID: 34875873 Review.

2

Differences in Self-identification of Opioid Overdose Risk and Naloxone Perceptions Between Therapeutic and Nontherapeutic Opioid Populations.

Ellis MS, Kasper ZA, Gold M, Cicero TJ. Ellis MS, et al. Among authors: gold m. J Addict Med. 2023 Mar-Apr 01;17(2):197-205. doi: 10.1097/ADM.0000000000001083. Epub 2022 Sep 22. J Addict Med. 2023. PMID: 36148998

3

Treatments for Cannabis Use Disorder across the Lifespan: A Systematic Review.

Ghafouri M, Correa da Costa S, Zare Dehnavi A, Gold MS, Rummans TA. Ghafouri M, et al. Among authors: gold ms. Brain Sci. 2024 Feb 28;14(3):227. doi: 10.3390/brainsci14030227. Brain Sci. 2024. PMID: 38539616 Free PMC article. Review.

4

Medicinal Marijuana, Stress, Anxiety, and Depression: Primum non nocere.

Gold M. Gold M. Mo Med. 2020 Sep-Oct;117(5):406-411. Mo Med. 2020. PMID: 33311739 Free PMC article. Review. No abstract available.

5

Opioid Dosage Levels, Concurrent Risk Factors and Self-Perceptions among Chronic Pain, Opioid-Managed Individuals at Elevated Risk for Opioid Overdose.

Ellis MS, Kasper ZA, Gold M, Cicero TJ. Ellis MS, et al. Among authors: gold m. Pharmaceuticals (Basel). 2021 Dec 8;14(12):1279. doi: 10.3390/ph14121279. Pharmaceuticals (Basel). 2021. PMID: 34959679 Free PMC article.

6

Psychedelic drugs for psychiatric disorders.

da Costa SC, Oesterle T, Rummans TA, Richelson E, Gold M. da Costa SC, et al. J Neurol Sci. 2022 Sep 15;440:120332. doi: 10.1016/j.jns.2022.120332. Epub 2022 Jul 5. J Neurol Sci. 2022. PMID: 35841696 Review.

7

Dopaminergic dysfunction: Role for genetic & epigenetic testing in the new psychiatry.

Blum K, Ashford JW, Kateb B, Sipple D, Braverman E, Dennen CA, Baron D, Badgaiyan R, Elman I, Cadet JL, Thanos PK, Hanna C, Bowirrat A, Modestino EJ, Yamamoto V, Gupta A, McLaughlin T, Makale M, Gold MS. Blum K, et al. Among authors: gold ms. J Neurol Sci. 2023 Oct 15;453:120809. doi: 10.1016/j.jns.2023.120809. Epub 2023 Sep 23. J Neurol Sci. 2023. PMID: 37774561

8

A Narrative Review of Current and Emerging Trends in the Treatment of Alcohol Use Disorder.

Celik M, Gold MS, Fuehrlein B. Celik M, et al. Among authors: gold ms. Brain Sci. 2024 Mar 20;14(3):294. doi: 10.3390/brainsci14030294. Brain Sci. 2024. PMID: 38539681 Free PMC article. Review.

9

Opioid use disorder: current trends and potential treatments.

Lee YK, Gold MS, Blum K, Thanos PK, Hanna C, Fuehrlein BS. Lee YK, et al. Among authors: gold ms. Front Public Health. 2024 Jan 25;11:1274719. doi: 10.3389/fpubh.2023.1274719. eCollection 2023. Front Public Health. 2024. PMID: 38332941 Free PMC article. Review.

10

Infectious diseases occurring in the context of substance use disorders: A concise review.

Kolla BP, Oesterle T, Gold M, Southwick F, Rummans T. Kolla BP, et al. J Neurol Sci. 2020 Apr 15;411:116719. doi: 10.1016/j.jns.2020.116719. Epub 2020 Jan 31. J Neurol Sci. 2020. PMID: 32070807 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

783 results

Search Page